{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:01:50Z","timestamp":1781881310493,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515012148"],"award-info":[{"award-number":["2024A1515012148"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515012739"],"award-info":[{"award-number":["2024A1515012739"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119021","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:09:22Z","timestamp":1770239362000},"page":"119021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hexahydrocurcumin inhibits osteoclastogenesis and bone destruction in osteoporosis by targeting c-Src"],"prefix":"10.1016","volume":"196","author":[{"given":"Lihong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s13018-023-04051-6","article-title":"Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis","volume":"18","author":"Long","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.biopha.2026.119021_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116954","article-title":"Unraveling the molecular and immunological landscape: exploring signaling pathways in osteoporosis","volume":"177","author":"Amroodi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119021_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.thromres.2023.12.007","article-title":"Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: data from the CAR.BONE study","volume":"233","author":"Pasca","year":"2024","journal-title":"Thromb. Res"},{"issue":"11","key":"10.1016\/j.biopha.2026.119021_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.tem.2021.07.011","article-title":"Terpenoid treatment in osteoporosis: this is where we have come in research","volume":"32","author":"Bellavia","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2026.119021_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112384","article-title":"Rab11A functions as a negative regulator of osteoclastogenesis through dictating Lysosome-induced proteolysis of c-fms and RANK surface receptors","volume":"9","author":"Okusha","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2026.119021_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119021_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116422","article-title":"Icariin ameliorates osteoporosis in ovariectomized rats by targeting Cullin 3\/Nrf2\/OH pathway for osteoclast inhibition","volume":"173","author":"Si","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119021_bib8","article-title":"Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities","volume":"142","author":"Dang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119021_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113140","article-title":"Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways","volume":"151","author":"Liu","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119021_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100790","article-title":"Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation","volume":"296","author":"Matsubara","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfy284","article-title":"Doxorubicin induces ER calcium release via Src in rat ovarian follicles","volume":"168","author":"Aziz","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2026.119021_bib12","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1074\/jbc.M112.358796","article-title":"Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-\u03baB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway","volume":"287","author":"Tomomura","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","article-title":"Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation","volume":"231","author":"Negishi-Koga","year":"2009","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119021_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41419-018-0417-0","article-title":"Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119021_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153351","article-title":"Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of \u03b1v\u03b23 integrin and core-linked CD44","volume":"79","author":"Kim","year":"2020","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.biopha.2026.119021_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/0008-5472.CAN-10-0730","article-title":"Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer","volume":"71","author":"Thomas","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119021_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155688","article-title":"Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor","volume":"129","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.biopha.2026.119021_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/bcp.13869","article-title":"Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis","volume":"85","author":"Stone","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119021_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00223-015-0051-0","article-title":"Cathepsin K inhibition: a new mechanism for the treatment of osteoporosis","volume":"98","author":"Duong le","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clinthera.2017.11.011","article-title":"Phase 1b study of the safety, pharmacokinetics, and disease-related outcomes of the matrix Metalloproteinase-9 Inhibitor Andecaliximab in patients with rheumatoid arthritis","volume":"40","author":"Gossage","year":"2018","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2026.119021_bib21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","article-title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial","volume":"15","author":"Stupp","year":"2014","journal-title":"Lancet Oncol."},{"issue":"27","key":"10.1016\/j.biopha.2026.119021_bib22","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1200\/JCO.2010.34.4994","article-title":"Emerging therapies to prevent skeletal morbidity in men with prostate cancer","volume":"29","author":"Saylor","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119021_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fcell.2020.00507","article-title":"Osteoclast signal transduction during bone metastasis formation","volume":"8","author":"Gy\u0151ri","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"23","key":"10.1016\/j.biopha.2026.119021_bib24","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1158\/1078-0432.CCR-15-2845","article-title":"TBCRC-010: phase I\/II study of dasatinib in combination with zoledronic acid for the treatment of breast cancer bone metastasis","volume":"22","author":"Mitri","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119021_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114850","article-title":"Understanding the mechanistic potential of plant based phytochemicals in management of postmenopausal osteoporosis","volume":"163","author":"Sharma","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119021_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155141","article-title":"Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1\/STAT3 signaling pathway","volume":"122","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"issue":"529","key":"10.1016\/j.biopha.2026.119021_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6143","article-title":"Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases","volume":"12","author":"Zhu","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119021_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-007-0773-9","article-title":"Involvement of alpha(v)beta3 integrins in osteoclast function","volume":"25","author":"Nakamura","year":"2007","journal-title":"J. Bone Min. Metab."},{"issue":"10","key":"10.1016\/j.biopha.2026.119021_bib29","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.2001.16.10.1747","article-title":"Cathepsin K, osteoclastic resorption, and osteoporosis therapy","volume":"16","author":"Zaidi","year":"2001","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.biopha.2026.119021_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/512926","article-title":"The role of Src kinase in macrophage-mediated inflammatory responses","volume":"2012","author":"Byeon","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000480067","article-title":"Effect of concurrent src kinase inhibition with short-duration hypothermia on Ca2+\/Calmodulin Kinase IV activity and neuropathology after Hypoxia-Ischemia in the newborn swine brain","volume":"113","author":"Kratimenos","year":"2018","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010180","article-title":"Finely-tuned calcium oscillations in osteoclast differentiation and bone resorption","volume":"22","author":"Okada","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119021_bib33","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1111\/jcmm.14700","article-title":"Aspeoxidative stressrpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca(2+) signalling and oxidative stress","volume":"23","author":"Chen","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.0105-2896.2009.00849.x","article-title":"Transcriptional regulation of bone and joint remodeling by NFAT","volume":"233","author":"Sitara","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2026.119021_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116166","article-title":"Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function","volume":"171","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697137.2021.1951206","article-title":"Osteoporosis and fractures in women: the burden of disease","volume":"25","author":"Lorentzon","year":"2022","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.biopha.2026.119021_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s13018-023-04152-2","article-title":"Bioinformatics and machine learning were used to validate glutamine metabolism-related genes and immunotherapy in osteoporosis patients","volume":"18","author":"Wang","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.biopha.2026.119021_bib38","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3389\/fimmu.2018.02263","article-title":"Bone remodeling and the role of TRAF3 in osteoclastic bone resorption","volume":"9","author":"Boyce","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119021_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.15605\/jafes.033.02.13","article-title":"Osteonecrosis of the jaw and bilateral atypical femoral fracture both occurring during treatment for osteoporosis: a case report","volume":"33","author":"Payumo","year":"2018","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"issue":"4","key":"10.1016\/j.biopha.2026.119021_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13139-018-0533-x","article-title":"Prevalence and risk factors of atypical femoral fracture bone scintigraphic feature in patients experiencing bisphosphonate-related osteonecrosis of the jaw","volume":"52","author":"Lee","year":"2018","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.biopha.2026.119021_bib41","first-page":"209","article-title":"Observational study of the bisphosphonate-related osteonecrosis of jaws","volume":"91","author":"Lungu","year":"2018","journal-title":"Clujul Med."},{"issue":"8","key":"10.1016\/j.biopha.2026.119021_bib42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/carcin\/bgaa002","article-title":"APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status","volume":"41","author":"Udquim","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2026.119021_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2018.03.030","article-title":"Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin","volume":"646","author":"Huang","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2026.119021_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154606","article-title":"Retinal protective effect of curcumin metabolite hexahydrocurcumin against blue light-induced RPE damage","volume":"110","author":"Lin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119021_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111113","article-title":"17\u03b1-Estradiol prevents ovariectomy-mediated obesity and bone loss","volume":"142","author":"Mann","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119021_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043772","article-title":"Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs","volume":"24","author":"Iantomasi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119021_bib47","first-page":"178","article-title":"Cycloastragenol prevents bone loss via inhibiting osteoclast activity in glucocorticoid-induced osteonecrosis of the femoral head: an in vivo study","volume":"45","author":"Wang","year":"2024","journal-title":"J. Orthop. Transl."},{"issue":"9","key":"10.1016\/j.biopha.2026.119021_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8090325","article-title":"Clinical aspects and current therapeutic approaches for FOP","volume":"8","author":"Kitoh","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.biopha.2026.119021_bib49","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bone.2011.12.017","article-title":"Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study","volume":"50","author":"Hannon","year":"2012","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.biopha.2026.119021_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105508","article-title":"Tyrosine Kinase Src is a regulatory factor of bone homeostasis","volume":"23","author":"Matsubara","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119021_bib51","article-title":"Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119021_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040861","article-title":"Estradiol and estrogen-like alternative therapies in use: the importance of the selective and non-classical actions","volume":"10","author":"Farkas","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119021_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41420-018-0134-6","article-title":"Epigenetic regulation of NfatC1 transcription and osteoclastogenesis by nicotinamide phosphoribosyl transferase in the pathogenesis of arthritis","volume":"5","author":"Li","year":"2019","journal-title":"Cell Death Discov."},{"issue":"8","key":"10.1016\/j.biopha.2026.119021_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95042","article-title":"Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva","volume":"6","author":"Williams","year":"2021","journal-title":"JCI Insight"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:42:26Z","timestamp":1781880146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"alternative-id":["S0753332226000533"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hexahydrocurcumin inhibits osteoclastogenesis and bone destruction in osteoporosis by targeting c-Src","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119021"}}